Advertisement
The Body: The Complete HIV/AIDS Resource Follow Us Follow Us on Facebook Follow Us on Twitter
Professionals >> Visit The Body PROThe Body en Espanol
Home Page for TheBody.com, the Complete HIV/AIDS Resource What's New About HIV Ask the Experts About HIV HIV/AIDS Blogs Connect With Others About HIV Just Diagnosed With HIV HIV Treatment HIV Prevention Living With HIV Personal Stories of People With HIV
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

News Briefs

FDA OKs Once-Daily Form of Drug Sustiva

From U.S. Centers for Disease Control and Prevention

February 5, 2002

US drug giant Bristol-Myers Squibb Co. said on Monday that the Food and Drug Administration has approved a once-daily tablet of its HIV treatment Sustiva. Currently the drug must be taken in the form of three 200-milligram tablets daily. The New York-based company said the 600-milligram tablet will make it easier for HIV patients to comply with their drug regimens. The 600-mg tablet will be available late this month in one-month supplies of 30 per bottle. The 200-mg version will continue to be offered for those who prefer it.


Back to other CDC news for February 5, 2002

Previous Updates

Adapted from:
Reuters
02.04.02

  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary
This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
 
 

Advertisement